Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome
Abstract. Objective. Cryopyrin-associated periodic syndrome (CAPS) is a heterogeneous group of diseases characterized by excessive IL-1β release resulting in s
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2016
|
| In: |
Rheumatology
Year: 2015, Volume: 55, Issue: 4, Pages: 689-696 |
| ISSN: | 1462-0332 |
| DOI: | 10.1093/rheumatology/kev416 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1093/rheumatology/kev416 Verlag, Volltext: https://academic.oup.com/rheumatology/article/55/4/689/1833374 
|
| Author Notes: | Jasmin B. Kuemmerle-Deschner, Ferdinand Hofer, Theresa Endres, Birgit Kortus-Goetze, Norbert Blank, Elisabeth Weißbarth-Riedel, Catharina Schuetz, Tilmann Kallinich, Karoline Krause, Christoph Rietschel, Gerd Horneff and Susanne M. Benseler |
| Summary: | Abstract. Objective. Cryopyrin-associated periodic syndrome (CAPS) is a heterogeneous group of diseases characterized by excessive IL-1β release resulting in s |
|---|---|
| Item Description: | Advance Access publication 14 December 2015 Gesehen am 22.11.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1462-0332 |
| DOI: | 10.1093/rheumatology/kev416 |